UCLA Fielding School of Public Health, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., CHS 60-054, Los Angeles, CA, 90095, USA.
UCLA Louise M. Darling Biomedical Library, 12-077 Center for Health Sciences, Los Angeles, CA, 90095-1798, USA.
Syst Rev. 2024 Jun 14;13(1):156. doi: 10.1186/s13643-024-02560-x.
Hematopoietic stem cell transplantation (HSCT) is a life-saving treatment for adolescents and young adults (ages 15-39) with hematologic malignancy. Given the significant developmental milestones usually achieved during this unique life stage, this population is especially vulnerable to the interruption caused by a cancer diagnosis and its treatment. HSCT is a particularly invasive form of cancer therapy with many negative physical, social, and psychological sequelae. The long-term impact of HSCT in adolescents and young adults with hematologic malignancies warrants a systematic investigation of its effects to best shape clinical care and health policy.
This protocol for a systematic review will focus on the long-term physical, psychological, social, spiritual, and health behavior effects experienced by adolescents and young adults who undergo HSCT for hematologic malignancy. We have constructed a specific search strategy that queries these five domains, which will be applied to five databases-Embase, PubMed, Cochrane Trials and Reviews, PsychInfo, and CINAHL-to identify the key literature. Two independent reviewers will perform a title/abstract screen followed by a full-text screen using standard screening templates to ensure the inclusion of outcomes in the post-acute HSCT period. Risk of bias will be assessed using the University of Adelaide Joanna Briggs Institute Collaboration Critical Appraisal Tools. Data from included studies will be abstracted on study characteristics, study setting, sample characteristics, and outcomes. Given the broad scope of the research question, data synthesis will focus on qualitative methods in accordance with Institute of Medicine standards.
While adolescents and young adults undergoing hematopoietic stem cell transplantation for hematologic malignancy are understood to have a unique survivorship experience, the sequelae of this treatment approach in this population have not been previously aggregated. This systematic review intends to expand insight into the adolescent and young adult experiences with HSCT in order to inform age-appropriate survivorship care and deliver this life-saving intervention with the best possible outcomes.
PROSPERO CRD42022361663.
造血干细胞移植(HSCT)是挽救 15-39 岁青少年和年轻成人血液系统恶性肿瘤的一种治疗方法。鉴于这个独特的生命阶段通常会达到重要的发育里程碑,因此该人群特别容易受到癌症诊断及其治疗的干扰。HSCT 是一种特别具有侵袭性的癌症治疗方法,会带来许多负面的身体、社会和心理后果。血液系统恶性肿瘤青少年和年轻成人接受 HSCT 的长期影响需要对其影响进行系统调查,以最佳地塑造临床护理和卫生政策。
本系统评价方案将重点关注接受造血干细胞移植治疗血液系统恶性肿瘤的青少年和年轻成人经历的长期身体、心理、社会、精神和健康行为方面的影响。我们构建了一个特定的搜索策略,查询这五个领域,该策略将应用于五个数据库 - Embase、PubMed、Cochrane 临床试验和评价、PsychInfo 和 CINAHL,以确定关键文献。两名独立的审查员将使用标准筛选模板进行标题/摘要筛选,然后进行全文筛选,以确保在急性 HSCT 后时期纳入结果。使用阿德莱德大学 Joanna Briggs 研究所合作批判性评估工具评估偏倚风险。将从纳入研究中提取研究特征、研究设置、样本特征和结局的数据。鉴于研究问题的广泛范围,数据综合将根据医学研究所的标准侧重于定性方法。
虽然接受造血干细胞移植治疗血液系统恶性肿瘤的青少年和年轻成人被认为具有独特的生存体验,但该人群中这种治疗方法的后遗症尚未被汇总。本系统评价旨在更深入地了解青少年和年轻成人接受 HSCT 的体验,以便为年龄适宜的生存护理提供信息,并以尽可能最好的结果提供这种救命的干预措施。
PROSPERO CRD42022361663。